Skip to content
value.today
Oligasis, LLC logo

Oligasis, LLC

Total raised
$36 M
2 rounds on record
Latest round
$34 M
Sep 2015
First round on record
Jul 2009
Today
Went public
See the company page

Oligasis, LLC is listed today as Kodiak Sciences Inc.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Oligasis, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2015$34 MNo. 2$10 to $50 million

Oligasis, LLC: Raise no. 2, Sep 2015

Investors in this round

13 investors had bought by the notice of Mar 24, 2016: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Oligasis, LLC as a whole in other filings: see Investors below.

What the notice says

Amount sold
$34 M of $34 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Borgeson · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carly Brower, Attorney-in-Fact under Power of Attorney dated 3/17/2016. Source: SEC Form D, newest notice filed Mar 24, 2016. Read the notice at the SEC.

equitySEC
Jul 2009$2 MNo. 1Under $2 million

Oligasis, LLC: Raise no. 1, Jul 2009

Investors in this round

26 investors had bought by the notice of Jul 28, 2009: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Oligasis, LLC as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Steven Charles · Executive Officer, Director
  • Victor Perlroth · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Victor Perlroth, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 28, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Oligasis, LLC chose not to state its revenue in its newest notice of a funding round (Mar 2016).

    SEC Form D · Mar 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2016

That is all the official record says: Oligasis, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Oligasis, LLC are on record.

Investors#

5 named in official filings. Open an investor to see everything it has backed.

Investors in Oligasis, LLC
InvestorKindAmountRoundRoleSource
667, L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2018)SEC Form 3
Baker Bros. Advisors (GP) LLCFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2018)SEC Form 3
Baker Bros. Advisors LPFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2018)SEC Form 3
Baker Brothers Life Sciences LPFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2018)SEC Form 3
Victor PerlrothPersonnot statednot statedHeld Series A preferred stock, 10% owner, director (Form 3, 2018)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 26 investors.

Largest shareholders today

Institutions holding Kodiak Sciences Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Oligasis, LLC
NameRoleNamed in
John BorgesonExecutive officerMar 2016
Steven CharlesExecutive officerJul 2009
Victor PerlrothExecutive officerJul 2009
Steven CharlesDirectorJul 2009
Victor PerlrothDirectorJul 2009

About

Biotech company.

Went public since 2018. Its SEC number is that of a company listed on a stock exchange.